These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Cerebrosclerosis, motor recovery and mental disorders]. Niquet G Lille Med; 1972 Feb; 17():Suppl 2:187-90. PubMed ID: 5034401 [No Abstract] [Full Text] [Related]
43. [Clinical pharmacology of the GABAergic system (II)]. Marco Igual M Med Clin (Barc); 1994 Jun; 103(1):22-9. PubMed ID: 8051963 [No Abstract] [Full Text] [Related]
44. [Mechanism of action of psychopharmaca]. Roos BE Nord Med; 1967 Dec; 78(50):1651-2. PubMed ID: 6073280 [No Abstract] [Full Text] [Related]
45. Pericyazine in clinical practice. Jenner FA Laval Med; 1970 Jun; 41(6):796-804. PubMed ID: 5509701 [No Abstract] [Full Text] [Related]
47. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome]. Elie R; Morin L; Tétreault L Encephale; 1972; 61(1):32-52. PubMed ID: 4403697 [No Abstract] [Full Text] [Related]
48. [Therapeutic use of Majeptil in psychiatric emergencies]. Martin CA; Johnson G; Petitclerc R Laval Med; 1965 Sep; 36(7):652-5. PubMed ID: 4379018 [No Abstract] [Full Text] [Related]
49. [Preliminary notes on the therapeutic action of propericiazine in tics]. Mironi F; Violante A G Psichiatr Neuropatol; 1968; 96(1):215-22. PubMed ID: 4388739 [No Abstract] [Full Text] [Related]
50. Drugs in psychiatry. Varma LP J Indian Med Assoc; 1971 Mar; 56(5):128-34. PubMed ID: 5121873 [No Abstract] [Full Text] [Related]
51. [Neuroleptic drugs]. Mårtens S Nord Med; 1967 Dec; 78(50):1639-43. PubMed ID: 4294514 [No Abstract] [Full Text] [Related]
52. [On the methods of testing of psychopharmaceutical agents. Clinical combined testing of thioproperazine]. Eckmann F; Immich H; Schäpperle O; Schwarz H; Tempel H Munch Med Wochenschr; 1967 Mar; 109(10):529-31. PubMed ID: 4384812 [No Abstract] [Full Text] [Related]
53. [Considerations on the clinical effects of a phenothiazine derivative: propericiazine or Fi 6145]. Del Monaco S; Annese A G Psichiatr Neuropatol; 1966; 94(2):405-15. PubMed ID: 5955004 [No Abstract] [Full Text] [Related]
56. [Self criticism and real role of the same drug]. Ostaptzeff M; Lavoine JR; Ostaptzeff G Ann Med Psychol (Paris); 1974 Feb; 1(2):264-77. PubMed ID: 4849685 [No Abstract] [Full Text] [Related]
57. [Clinical and experimental observations with chloracizine]. Korolenko CP; Volkov PP; Pantelejev VI Cesk Psychiatr; 1968 Oct; 64(5):345-8. PubMed ID: 5701273 [No Abstract] [Full Text] [Related]
58. The prevalence of tardive dyskinesias in mental hospital patients. Fann WE; Davis JM; Janowsky DS Dis Nerv Syst; 1972 Mar; 33(3):182-6. PubMed ID: 5022453 [No Abstract] [Full Text] [Related]
59. [Classification of psychopharmaca]. Bílý J Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(5):707-9. PubMed ID: 5257736 [No Abstract] [Full Text] [Related]
60. [Progress and limitation of psychopharmacological therapy]. Hoff H; Hofmann G Psychiatr Neurol Med Psychol (Leipz); 1967 Dec; 19(12):441-8. PubMed ID: 6082949 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]